Skip to main content
RGNX logo

RGNX · REGENXBIO Inc. · Documents

Track RGNX — free
$7.16 -0.02 (-0.28%) At close · Nov 20 Play latest call Q3 2026 earnings call transcript
Market Cap
$473.44M
Shares
66.12M
Volume · Nov 20 1.06M Avg daily vol (3M) 1.38M

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

2022
Mar 1
Annual report 10-K FY2021, ended Dec 31
Annual report for FY2021
Revenue $470.35M ▲ 204.3% Net income $127.84M Diluted EPS $2.91
2021
Mar 1
Annual report 10-K FY2020, ended Dec 31
Annual report for FY2020
Revenue $154.57M ▲ 338.7% Net loss $111.25M Diluted EPS -$2.98
2020
Showing 101–150 of 160 documents
Key facts CIK 1590877 CUSIP 75901B107 13F (30d) 173 filings 157 filers Visit website Investor relations